Herein, anti-CD19 CAR T cells engineered to secret IL-7 and CCL19 are used to treat diffuse large B cell Lymphomas (NCT04381741, NCT04833504), aiming at promoting tumor infiltration, accumulation, and survival of CAR T cells in cancerous tissue [111]. This evidence concerns the gene CCL19 and neoplasm.